Kristin Goddard - Concepedia

Author

Kristin Goddard

Kaiser Permanente ORCID

Also Known As

Bradley Crane, K Goddard, K. Goddard, Kristin Goddard, Kristin S. Goddard, Ned Lewis, Xi Zeng

114

Publications

5.4K

Citations

H-Index

Concepts

All Affiliations

Kaiser Permanente Centers for Disease Control and Prevention Kaiser Permanente Center for Health Research HealthPartners National Center for Immunization and Respiratory Diseases

About

Kristin Goddard is an author at Kaiser Permanente specializing in vaccination, medicine, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	17	720
2	Public Health	14	15	557
3	Health Sciences	2	2	152
4	Nursing	1	1	126
5	Allergy	1	1	21

Kristin Goddard

Publications

4.9K

Citations

H-Index

Page 1

	Year	Citations
Surveillance for Adverse Events After COVID-19 mRNA Vaccination Nicola P. Klein, Ned Lewis, Kristin Goddard, JAMA	2021	627
Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings Mark G. Thompson, Edward Stenehjem, Shaun J. Grannis, New England Journal of Medicine	2021	490
Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022 Jill M. Ferdinands, Suchitra Rao, Brian E. Dixon, MMWR Morbidity and Mortality Weekly Report	2022	466
Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022 Mark G. Thompson, Karthik Natarajan, Stephanie A. Irving, MMWR Morbidity and Mortality Weekly Report	2022	427
Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study Jill M. Ferdinands, Suchitra Rao, Brian E. Dixon, BMJ	2022	194
Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years — VISION Network, 10 States, April 2021–January 2022 Nicola P. Klein, Melissa S. Stockwell, Maria Demarco, MMWR Morbidity and Mortality Weekly Report	2022	192
Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults — Nine States, January–September 2021 Peter J. Embí, Matthew E. Levy, Allison L. Naleway, MMWR Morbidity and Mortality Weekly Report	2021	188
Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink Kayla E. Hanson, Kristin Goddard, Ned Lewis, JAMA Network Open	2022	152
Overdose Education and Naloxone for Patients Prescribed Opioids in Primary Care: A Qualitative Study of Primary Care Staff Ingrid A. Binswanger, Stephen Koester, Shane R. Mueller, Journal of General Internal Medicine Opioid EpidemicFamily MedicineSubstance UsePrimary Care StaffHarm Reduction	2015	126
Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated — VISION Network, 10 States, December 2021–June 2022 Ruth Link‐Gelles, Matthew E. Levy, Manjusha Gaglani, MMWR Morbidity and Mortality Weekly Report	2022	124

Page 1